No contraindication for surgery
Known hypersensitivity to the trial drugs or other contraindication to standard “7+3” induction chemotherapy
Any medical or physical contraindication, or other inability to undergo hematopoietic progenitor cell (HPC) collection
Surgery, unless documented contraindication
Radiotherapy, unless documented contraindication
Chemotherapy, unless documented contraindication
Contraindication to angiography or chemoembolization medications
History of thromboembolic disease or uterine cancer that is considered a contraindication to tamoxifen
Known contraindication to phosphodiesterase-5 inhibitors (e.g. currently on nitrates)
Any known factors that would pose a contraindication to receiving nivolumab
History of documented anaphylaxis or contraindication to any of the study medications
Contraindication to epidural per Pain Service guidelines
All patients with tumors involving the thoracic esophagus must undergo bronchoscopy to document the absence of a fistula no known contraindication to the use of taxanes or platinum compounds
Contraindication to angiography/embolization procedure based on judgment of the treating investigator
Contraindication to MRI
Participant has a contraindication to biopsy
Medical contraindication to receipt of radiotherapy
No contraindication to tumor biopsy at time of study enrollment
Patients in whom there is a medical contraindication or potential problem in complying with the requirements of the protocol, in the opinion of the investigator.
Contraindication to any concomitant medication, including antivirals, anticoagulation prophylaxis, tumor lysis prophylaxis, or hydration given prior to therapy
Contraindication to RPFNA including breast implant(s), bilateral radiation, anticoagulation (excluding those on 81 mg aspirin)
Contraindication to receiving radiotherapy
Known contraindication for topotecan or temozolomide
Extensive loculations or hydropneumothorax or other contraindication to pleurodesis
Contraindication or precaution for enzalutamide
Has a contraindication (sensitivity or allergy) to trimethoprim/sulfamethoxazole and ampicillin.
Contraindication to receive radiotherapy
Contraindication to IV contrast
Patients with contraindication to thromboprophylaxis
Any contraindication to therapy with nivolumab
Medical contraindication to radiation treatment (e.g. active systemic sclerosis, other uncontrolled autoimmune condition)
CRITERIA FOR SCREENING: Any known and irreversible contraindication to huJCAR014 therapy
Contraindication to the use of PTX
Has a history or current evidence of physical or physiological contraindication to participation in this study, at the discretion of the treating investigator
Patients with any contraindication to receiving rhuGM-CSF based products
Absence of contraindication for Ommaya reservoir
Any contraindication to the combination anti-cancer agent as per local prescribing information
Contraindication to any of the individual components of CHOP, including prior receipt of anthracyclines
Active uncontrolled infection that would be a contraindication to safe use of high-dose therapy
Contraindication to any concomitant medication, including pre-medications or hydration given prior to therapy
No contraindication to be on a minimum of 81 mg aspirin a day (or other anticoagulant therapy as prescribed) for thromboembolism prophylaxis
Contraindication to intravenous (IV) contrast
Patients who have contraindication to cyclophosphamide chemotherapy
Contraindication for undergoing MRIs
Subjects with a contraindication to MR-HIFU.
Medical contraindication to the use of varenicline OR nicotine patch
Medical contraindication to the use of bupropion
Patients with any contraindication to receiving rhuGM-CSF based products
Contraindication to receiving HCQ or TACE
Contraindication to or unwillingness to undergo study related procedures including a repeat bronchoscopy
The patient has a contraindication (e.g. sensitivity/allergy) to both trimethoprim/sulfamethoxazole and ampicillin
Contraindication or unwillingness to undergo multiple CT scans
Contraindication to receiving radiotherapy or TACE
Presenting with a general or visceral contraindication to intensive treatment including:
Patient has a known hypersensitivity or contraindication to study products that, in the opinion of the investigator, cannot be adequately pre-medicated
Patient with contraindication for imaging with MRI
HAPLOIDENTICAL RELATED DONOR: History of other medical conditions that in the opinion of PI constitute a contraindication to donation
Requires treatment with other medications that cannot be stopped and for which there is a known contraindication to co-administration of one or more of the study drugs.
Have known contraindication to Gd-MRI.
Medical contraindication to apheresis
Contraindication for MRI scanning (as assessed by local MRI safety questionnaire), which includes but is not limited to:
Patients with contraindication for treatment by laparoscopy
Known contraindication to aromatase inhibitor or SERM therapy
Part 2: have a major contraindication to MP (e.g., allergy/hypersensitivity to study medications or their constituents), or conditions making adherence difficult as determined by the attending physician
Has a contraindication to administration of amoxicillin, ampicillin, ciprofloxacin, erythromycin, gentamycin, penicillin, trimethoprim/sulfamethoxazole, and vancomycin
Participants in whom there is a medical contraindication or potential problem in complying with the requirements of the protocol, in the opinion of the investigator
Any medical or physical contraindication or any other inability to undergo HSPC collection
Any medical or physical contraindication or other inability to undergo HSPC collection
Contraindication to cisplatin chemotherapy or plans to alter or reduce cisplatin therapy
Contraindication to treatment for TE prophylaxis
Contraindication to any drug in the chemotherapy regimen, and specifically
Has a contraindication to administration of ampicillin or trimethoprim/ sulfamethoxazole.
Any contraindication to oral agents.
Known or suspected hypersensitivity to ofatumumab or SB-485232 that in the opinion of the investigator is a contraindication to their participation in the study
Contraindication to any concomitant medication, including antivirals, anticoagulation prophylaxis, tumor lysis prophylaxis, or hydration given prior to therapy
Medical contraindication to undergoing MR imaging
Contraindication to all available herpes simplex virus (HSV)/varicella prophylactic antiviral drugs
Patients who have contraindication to MRI
Has a contraindication to administration of trimethoprim/sulfamethoxazole or ampicillin.
Any contraindication to ECP, i.e. contraindication to heparin or methoxsalen (8-MOP)
Has a contraindication to administration of trimethoprim/sulfamethoxazole or ampicillin.
Clear contraindication for systemic corticosteroids (diabetes mellitus is not per se a clear contraindication);
Patients with contraindication to thromboprophylaxis
Contraindication to MRI
Participants with contraindication to RT while adjuvant RT is clinically indicated
Contraindication to any concomitant medication, including antivirals or anticoagulation
Contraindication to any concomitant medication, including antivirals, anticoagulation prophylaxis, tumor lysis prophylaxis, or hydration given prior to therapy.
Contraindication to any concomitant medication, including antivirals or anticoagulation
Contraindication to heparin as per NCCN guidelines
Contraindication to corticosteroids
Contraindication to EUS-guided needle puncture into the pancreas
Patients with contraindication to steroid use
Contraindication to chemotherapy or radiation
Contraindication to gadolinium-enhanced MRI imaging
Patients with a contraindication (e.g. sensitivity/allergy) to trimethoprim/sulfamethoxazole or ampicillin
Contraindication to any concomitant medication, including antivirals or anticoagulation
Any contraindication for TACE.
Any contraindication for doxorubicin administration:
Subjects with an absolute contraindication to corticosteroid administration
Contraindication to propranolol, etodolac
Patients with any known contraindication to treatment with, including hypersensitivity to quinacrine or erlotinib
Contraindication to concomitant anticoagulation prophylaxis
Any other contraindication listed in the local labeling of dalteparin, enoxaparin, or edoxaban;
Any contraindication to MRI examination
Contraindication to potential treatment agents
Known hypersensitivity or contraindication to study drugs, oxazolidinones, or quinolones.
Known contraindication to dexamethasone
Contraindication to any of the required concomitant drugs, including antiviral (e.g. Valacyclovir)
Contraindication for all comparators:
Patients with contraindication to dexamethasone.
Any contraindication to gemcitabine therapy
Known or suspected hypersensitivity to ofatumumab or bendamustine that in the opinion of the investigator is a contraindication to their participation in the present study.
Contraindication for nicotine patch use
History of documented anaphylaxis or contraindication to any of the study medications
Contraindication or allergy to intravenous lidocaine
Subject, as deemed by treating investigator has contraindication to endoscopy or Spray Cryotherapy Procedure.
Any contraindication to cardiac stress testing
Patients with a history of documented anaphylaxis or contraindication to any of the study medications or standardized intra-operative medications; these include Dilaudid, fentanyl, and bupivacaine
Major contraindication to methylphenidate i.e. hypersensitivity
Medical contraindication to exercise
Pregnant patients will not be included in the study as pregnancy is a relative contraindication for these types of surgical procedures
Major contraindication to ginseng: allergy/hypersensitivity to Panax species or their constituents (history of arrhythmias, agitation, or motor tics, or severe angina pectoris)
Contraindication to placement of an IPC (e.g., uncorrected coagulopathy)
Known contraindication to receiving G-CSF
Allergy or other contraindication to morphine sulfate
Participant has allergy or other contraindication for morphine or gabapentin therapy
Contraindication for the nicotine patch (e.g., heart attack, angina, skin allergies) unless a doctor’s note is provided.
Contraindication to NRT;
Medical contraindication to receipt of radiotherapy
Any contraindication for GVHD prophylaxis with mycophenolate mofetil, cyclosporine A, or tacrolimus
No known contraindication to NSAID use
Have no contraindication to NRT
Have a contraindication to NRT
Patients who have a contraindication to radiation therapy
Presence of any contraindication for a neurosurgical procedure
contraindication to anticoagulant therapy
Contraindication to MRI
Contraindication to PET
Contraindication to Lasix
Any contraindication to bronchoscopy, for example:
Inability or contraindication to undergo transcatheter arterial embolization
Study Note: a patient with a contraindication to MRI will be excluded from the MRI portion of the study, but will still be asked to continue with the biopsy and C13 glucose infusion portion of the trial
Known hypersensitivity to glucagon (contraindication for glucagon IV, required for endorectal MRI only)
Pheochromocytoma, insulinoma or galactosemia (contraindication for glucagon IV, required for endorectal MRI only)
Insulin?dependent diabetes (contraindication for glucagon IV, required for endorectal MRI only)
Contraindication to MRI
Contraindication to PET
Contraindication to MRI or history of adverse reaction to gadolinium
Contraindication for MP MRI
Known intolerance, hypersensitivity, or contraindication to glucocorticoids.
Contraindication or allergy to Feraheme (based on insert)
Contraindication to MRI
Contraindication to potassium iodide
Contraindication to prostate mpMRI (renal failure, hip prosthesis, pacemaker, etc)
Contraindication to prostate biopsy via transrectal or transperineal approaches (including coagulopathy)
Contraindication to use of fluoropyrimidines as a radiosensitizing agent
Contraindication to prostate biopsy
Claustrophobia or any other contraindication to MRI imaging evaluated by a standardized safety questionnaire
Patient who has a contraindication to endoscopy
Have no contraindication to short-term atorvastatin therapy
History of any condition deemed by the principal investigator to be a contraindication to B-WARM therapy (e.g., skin reaction, dysregulation of thermoregulation, etc)
Have a contraindication to NSAIDs at the oncologist’s discretion (i.e., allergy, worsening of ongoing medical problem due to NSAID, low platelet count from chemotherapy, and uncontrolled condition such as hypertension or asthma)
Contraindication to test article, constituents, or required concomitant medications
